Jazz's Xyrem Patent Cases Consolidated In NJ Fed Court
A New Jersey federal judge on Thursday ordered the consolidation of several infringement cases brought by Jazz Pharmaceuticals against other drug companies regarding its patents for Xyrem, a narcolepsy drug the...To view the full article, register now.
Already a subscriber? Click here to view full article